Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05815043 · ClinicalTrials.gov registry record · NA

Effects of Sodium Intake on Arterial Stiffness in Black Men and Women

A NA study of Arterial Stiffness and Sodium Intake, sponsored by Texas State University.

Completed
Registry status
NA
Development phase
34
Enrollment target
1
Study location

NCT05815043: Completed NA study of Arterial Stiffness and Sodium Intake, sponsored by Texas State University.

NCT05815043 is a NA study of Arterial Stiffness and Sodium Intake that has completed, run by Texas State University. The registered enrollment target is 34 participants, below the 120-participant average among 12 other Arterial Stiffness trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05815043, a NA study of Arterial Stiffness and Sodium Intake, has completed, sponsored by Texas State University.

COMPLETED
Registry status
NA
Development phase
34 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to explore the influence of sodium intake on arterial stiffness in African American/Black adults.

Primary Outcome

Cardio-ankle vascular index will be assessed using simultaneous arm and ankle blood pressures, EKG, and phonocardiography

Interventions

  • BEHAVIORAL Low-sodium intake
  • DIETARY_SUPPLEMENT High-sodium intake

Study Locations (1)

Texas

  • Texas State University - San Marcos

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2022-12-13
Est. Completion 2023-12-30
Phase NA
Texas State University

10 total trials

What the finished NCT05815043 record still lists

NCT05815043 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 120-participant average among 12 other Arterial Stiffness trials with a reported enrollment target (72% lower).

The record links to 2 conditions, with Arterial Stiffness appearing as the primary indexed condition, and to 2 interventions - of which Low-sodium intake is the first listed.

NCT05815043 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT05815043 about?

NCT05815043 is a clinical study titled "Effects of Sodium Intake on Arterial Stiffness in Black Men and Women". The purpose of this study is to explore the influence of sodium intake on arterial stiffness in African American/Black adults.

What is the current status of trial NCT05815043?

This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2022-12-13. Estimated completion is 2023-12-30.

What conditions does trial NCT05815043 study?

This clinical trial studies the following conditions: Arterial Stiffness, Sodium Intake.

What interventions are being tested in trial NCT05815043?

The interventions under investigation include: Low-sodium intake (BEHAVIORAL), High-sodium intake (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05815043?

This trial is sponsored by Texas State University, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05815043 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Arterial Stiffness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05815043's enrollment target sits among peer trials

34 8th of 12 higher than 5 of 12 other Arterial Stiffness trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Arterial Stiffness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02897063 · 34 participants · Phase 1

    Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

  • NCT03906617 · 34 participants · Phase 4

    Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine

  • NCT03992378 · 34 participants · NA

    Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis

  • NCT04047849 · 34 participants · Phase 4

    Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05815043, the US trial registry maintained by the National Library of Medicine. NCT05815043 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.